Quest Diagnostics Launches Convenient Self-Collection for GTI Testing

Quest Diagnostics Innovations in Genital Tract Infection Testing

Quest Diagnostics (NYSE: DGX) is revolutionizing the way patients access testing for genital tract infections (GTIs) with a groundbreaking self-collection service. This initiative aims to enhance discretion and convenience for individuals seeking testing and treatment for conditions like vaginitis, chlamydia, gonorrhea, trichomoniasis, and Mycoplasma genitalium.

Empowering Patients with Self-Collection Options

With this first-of-its-kind service, patients can collect swab specimens themselves at any of Quest's 2,000 patient service centers, provided they have a physician's order. This self-collection option is available at no additional cost, allowing patients to engage more actively in their healthcare.

Improving Accessibility to Health Services

“At Quest, our goal is to empower patients by offering them choices that enhance their healthcare experience,” shared Kathleen Valentine, Vice President and General Manager of Women's and Reproductive Health Services at Quest Diagnostics. By enabling self-collection, Quest is making significant strides toward improving access to vital sexual health testing.

The Self-Collection Process Explained

Utilizing the FDA-cleared Aptima® Multi-test swab, patients can self-collect vaginal specimens in a private setting at Quest's centers. The process is straightforward and guided by clear instructions. However, some individuals may find self-collection challenging and may need to consult a healthcare professional for assistance. Once collected, the specimens are forwarded to the laboratory for testing, delivering results electronically to both the patient and their healthcare provider.

The Importance of Timely Testing

Untreated GTIs can lead to severe long-term health issues, such as pelvic inflammatory disease, chronic pain, infertility, and complications during pregnancy. Recognizing these risks, Dr. Damian P. Alagia, Senior Medical Director at Quest, emphasizes that specimen self-collection offers women a comfortable alternative that maintains testing accuracy.

Overview of Common Infections Tested

The new self-collection method facilitates laboratory testing for various infections, notably bacterial vaginosis (BV), vulvovaginal candidiasis (commonly known as yeast infection), and trichomoniasis. Given that one in three women experiences vaginitis at some point in their lives, this service is a significant advancement in women's health.

Enhancing Patient Care and Experience

This innovative service allows patients to take charge of their health in a discreet manner, while also alleviating some of the burdens from healthcare providers who may be pressed for time. A recent survey found that over half of respondents prioritize convenience and accessibility when making healthcare decisions, underscoring the relevance of Quest's offering.

Choices Beyond the Patient Service Centers

In addition to utilizing physician orders, patients can also opt for self-collection through Quest's consumer-initiated testing platform. This platform provides a simple way to order labs for testing various GTIs and allows for follow-up consultations with licensed physicians through the PWNHealth network. This ensures that patients can receive comprehensive care based on their testing outcomes.

Quest Diagnostics Commitment to Health

Quest Diagnostics is dedicated to advancing health for individuals and communities. As a leading diagnostic provider, the company plays a key role in health management by delivering insights derived from extensive clinical data. Its diagnostic capabilities enable better identification, treatment, and overall management of health conditions across the United States, serving a significant portion of the adult population and healthcare practitioners.

Frequently Asked Questions

What types of infections can be tested with this new service?

The self-collection method is applicable for various infections, including bacterial vaginosis, candidiasis, trichomoniasis, chlamydia, and gonorrhea.

Do patients need a physician's order for self-collection?

Yes, a physician's order is required to utilize the self-collection option at Quest's patient service centers.

Is there an additional cost associated with self-collection?

No, there is no extra charge for patients choosing the self-collection option.

How does the self-collection process work?

Patients will receive step-by-step instructions for collecting samples in a private room, following which samples are sent to Quest for testing.

Can patients discuss results with a physician?

Yes, patients can consult with a licensed physician to discuss test results and receive potential treatment options.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.